GRP
ABOS icon

Global Retirement Partners’s Acumen Pharmaceuticals ABOS Stock Holding History

Global Retirement Partners’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,000
Closed -$7.26K – 3384
2023
Q4 		$7.26K Buy
+2,000
New +$5.94K ﹤0.01% 2187

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Global Retirement Partners's ABOS Position: Q1 2024 in Review

Global Retirement Partners sold out of Acumen Pharmaceuticals (ABOS) in Q1 2024, closing a stake of 2,000 shares — an estimated $7.26K sold.

Global Retirement Partners first reported a position in ABOS in Q4 2023 and held it in 1 quarter. The position peaked at $7.26K in Q4 2023. 80 funds tracked by Wall St. Rank hold ABOS as of Q1 2024.

  • Global Retirement Partners reported no remaining Acumen Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Global Retirement Partners sold 2,000 Acumen Pharmaceuticals shares in Q1 2024, an estimated $7.26K.
  • Global Retirement Partners first reported a position in Acumen Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Global Retirement Partners's Acumen Pharmaceuticals position peaked at $7.26K in Q4 2023.
  • 80 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2024.

Based on Global Retirement Partners's 13F filing for Q1 2024, filed 23 Apr 2024.